Canadian Coordinating Office for Health Technology Assessment
Office canadien de coordination de l'évaluation des technologies de la santé
VIAF ID: 124136868 ( Corporate )
Permalink: http://viaf.org/viaf/124136868
Preferred Forms
-
- 110 2 _ ‡a Canadian Coordinating Office for Health Technology Assessment
-
- 110 2 _ ‡a Canadian Coordinating Office for Health Technology Assessment
-
- 110 2 _ ‡a Office canadien de coordination de l'évaluation des technologies de la santé
-
4xx's: Alternate Name Forms (18)
5xx's: Related Names (4)
Works
Title | Sources |
---|---|
Analyses coût-efficacité et coût-utilité du finastéride dans le traitement de l'hypertrophie bénigne de la prostate | |
Annual report | |
Aperçu technol. | |
Assessment of videoconferencing in telehealth in Canada | |
Behavioural interventions for preschool children with autism | |
Bibliographie annotée des coûts et avantages des programmes de dépistage prénatal | |
Bisphosphonate agents for the management of pain secondary to bone metastases : a systematic review of effectiveness and safety | |
CCOHTA update. | |
Comparison of drug treatments for multiple sclerosis | |
Comparison of lung volume reduction surgery with medical management of emphysema | |
Connexion. | |
The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis of rheumatoid arthritis | |
Costs and outcomes of chiropractic treatment for low back pain | |
Criteria for selection of adult recipients for heart, cadaveric, kidney, and liver transplantaion | |
Drug treatments for Alzheimer's disease. II : A review of outcome measures in clinical trials | |
The efficacy of proton pump inhibitors in adults with functional dyspepsia | |
Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents : systematic review and budget impact analysis | |
Évaluation des techniques de dépistage du cancer du col utérin | |
Glycoprotein IIb/IIa antagonists : a systematic review of randomized clinical trials in patients undergoing percutaneous coronary intervention | |
Guide pour le processus d'évaluation des coûts : version 1.0 | |
Guidelines for economic evaluation of pharmaceuticals : Canada | |
HTA, health technology update | |
Impact of radiation wait times on risk of local recurrence of breast cancer : early stage cancer with no chemotheraoy | |
Les inhibiteurs de l'HMG-CoA réductase : analyse des études cliniques et des évaluations pharmacoéconomiques publiées | |
Les inhibiteurs spécifiques du recaptage de la sérotonine (ISRS) dans les cas de dépression majeure. | |
Interferon-based therapies for chronic hepatitis C virus infection : an assessment of clinical outcomes | |
Issues in emerging health technologies. | |
L'Exosurf néonatal utilisé dans le traitement substitutif du surfactant | |
Lignes dir. éval. écon. prod. pharm. Can | |
L'Influence des interventions éducatives sur les habitudes des médecins face à la prescription des examens | |
L'insuline lispro : une évaluation critique | |
L'introduction de la cholécystectomie laparoscopique au Canada et en Australie | |
Long-acting ß₂ -agonists for maintenance therapy of stable chronic obstructive pulmonary disease : a systematic review | |
Les Méthodes de traitement de la lithiase biliaire | |
New fluoroquinolones in community-acquired pneumonia : a clinical and economic evaluation | |
Notes technol. santé émerg. | |
Nouvelles de l'OCCETS. | |
Novel antipsychtics for patients with bipolar disorder : a systematic review | |
Oseltamivir for the treatment of suspected influenza : a clinical and economic evaluation | |
Predictive Genetic Testing for breast and prostate cancer | |
Produits pharmaceutiques | |
Radiofrequency catheter ablation for cardiac arrhythmias : a clinical and economic review | |
Raloxifene for primary and secondary prevention of osteoporotic fractures in postmenopausal women : a systematic review of efficacy and safety evindece | |
Rapp. technol. (Off. can. coordin. éval. technol. santé) | |
Rapport annuel | |
Rapport technologique | |
Répertoire des projets canadiens d'évaluation des technologies de la santé | |
Réutilisation des cathéters cardiaques à usage unique | |
Réutilisation des instruments médicaux jetables : compte rendu, les 6 et 7 octobre 1994, Montréal, Canada | |
A review of guidelines for referral of patients to sleep laboratories | |
The role of clapidogrel in the secondary prevention of recurrent ischemic vascular events after acute myocardial ischemia : a critical appraisal of CURE trial | |
Surveillnce mammography after treatment for primary breast cancer | |
A Survey of investigational new drug and emergency drug release policies, 1991: | |
Technology overview (Ottawa, Ont.) | |
Technology overview (Ottawa, Ont. : 1998) | |
Technology report (Canadian Coordinating Office for Health Technology Assessment) | |
Telephone triage services : systematic review and a survey of canadian call centre programs | |
Le Traitement chiropratique des cervicalgies et des lombalgies : recension d'études choisies | |
Treatment of inoperable advanced non-small-cell lung cancer : regimens with or without taxane | |
Use of cisapride in patients with nin-ulcer dyspepsia : a meta-analysis of randomized trials | |
Vue d'ensemble des principales études sur le dépistage du cancer du sein avec leurs conclusions |